# Mel Dixon

ตอนพอดคาสต์ยอดนิยม
อัปเดตแล้ว:

TER #012b - Inside NSW English Teachers Assoc 2013 Annual Conference, Part 2 - Dec 15 2013

In this 2 part special, Cameron reports from inside the 2013 NSW English Teachers' Association Annual Conference held on 22-23 November at the University of New South Wales. Interviews include,, President Karen Yager, Treasurer Susan Gazis, Executive Officer Eva Gold, Journal Editor Mel Dixon & Ass…

TER #012a - Inside NSW English Teachers Assoc 2013 Annual Conference, Part 1 - Dec 15 2013

In this 2 part special, Cameron reports from inside the 2013 NSW English Teachers' Association Annual Conference held on 22-23 November at the University of New South Wales. Interviews include,, President Karen Yager, Treasurer Susan Gazis, Executive Officer Eva Gold, Journal Editor Mel Dixon & Ass…

TER #012b - Inside NSW English Teachers Assoc 2013 Annual Conference, Part 2 - Dec 15 2013

In this 2 part special, Cameron reports from inside the 2013 NSW English Teachers' Association Annual Conference held on 22-23 November at the University of New South Wales. Interviews include,, President Karen Yager, Treasurer Susan Gazis, Executive Officer Eva Gold, Journal Editor Mel Dixon & Ass…

How can we work with patients to drive research initiatives?

In this episode, we explore the importance of patient involvement in shaping rare condition research initiatives. Our guests discuss why it’s crucial to involve individuals with lived experiences, including patients and caregivers, in setting research agendas. In doing so, this approach ensures res…

S5 E2 - DHDDS: Turning a Diagnosis into a Global Support Network

In this episode, Helen is in Guy's Hospital London, supported by the South East Genomic Medicine Service, talking to Mel Dixon about her experience with the rare genetic condition DHDDS. After two of Mel's children were diagnosed with DHDDS, Mel and her husband Charlie founded Cure DHDDS, a charity…

What if a treatment created for one person could transform care for thousands?

In this episode, we explore how individualised medicines are evolving from “n=1” treatments (a treatment effective for a single individual) into approaches that could transform care for many people living with rare conditions.  Advances in genomic medicine are making it possible to design highly t…